Scott+Scott Attorneys at Law LLP Announces Investigation into Solid Biosciences Inc. (SLDB)

NEW YORK, March 22, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether Solid Biosciences Inc. ("Solid Biosciences" or the "Company") (NASDAQ: SLDB) or certain of its officers and directors violated federal securities laws.  If you are a Solid Biosciences shareholder, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.

Solid Biosciences is a biotechnology company that develops therapies and devices for patients with duchenne muscular dystrophy ("DMD").

On March 14, 2018, the Company announced it received notification from the U.S. Food and Drug Administration ("FDA") that IGNITE DMD, its Phase I/II clinical trial for SGT-001 microdystrophin gene transfer in DMD, had been placed on Clinical Hold.

On this news, shares of Solid Biosciences fell $16.99 per share – over 64% – to close at $9.32 on March 15, 2018.

The Company held its initial public offering ("IPO") on January 26, 2018 at $16 per share; since then, the stock price has fallen nearly 47% as of market close on March 21, 2018.

What You Can Do

If you are a Solid Biosciences shareholder and you suffered a loss, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

CONTACT:

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Ave, 17^th Fl, NY, NY 10169
(844) 818-6982
jpettigrew@scott-scott.com

View original content:http://www.prnewswire.com/news-releases/scottscott-attorneys-at-law-llp-announces-investigation-into-solid-biosciences-inc-sldb-300618379.html

SOURCE Scott+Scott Attorneys at Law LLP